Term
Pathogens of Encephalitis |
|
Definition
Viral
- HSV (leading cause of severe encephalitis in all ages)
- Enterovirus
- EBV
- Adenovirus
- Arbovirus
- HIV
Bacterial
Neonates: Group B Streptococcus, Listeria monocytogenes, Citrobacter
Others: Borrelia burgdorferi, Bartonella henselae, Rickettsia rickettsii, Mycoplasma pneumoniae |
|
|
Term
Clinical Presentation of Encephalitis |
|
Definition
- Disturbance in brain function (psychiatric symptoms, emotional lability, altered sensorum, ataxia, movement disorders, focal neurologic deficit, paresis, stupor, coma, seizures)
- Fever
- Headache
- Personality change or irritability lasting for hours to days
- Lethargy (coma, death)
|
|
|
Term
|
Definition
- Lumbar puncture
- Culture blood, urine, nasopharyngeal, and stool
- Metabolic Screening
- MRI
- Serum Specimen: Mycoplasma serology
|
|
|
Term
Encephalitis CNS Findings |
|
Definition
- CSF cell count normaly to slightly elevated
- Protein normal to slightly elevated (high protein + polymorphonuclear pleocytosis = brain necrosis)
- Glucose normal
- Pleocytosis of mononuclear cells (elevated WBCs)
|
|
|
Term
|
Definition
Support Measures
- Airway protection
- Cerebral perfusion
- Seizure control
Empiric Acyclovir
- Needs to be started ASAP (better safe than sorry)
- For HSV
- Insufficient data to recommend for Mycoplasma treatment
|
|
|
Term
Signs/Symptoms of Bacterial Meningitis |
|
Definition
- High fever, headache, nuchal rigidity
- N/V, photophobia
- Confusion, sleepiness
- Seizures
- Children (lethargic, irritable, vomiting, feeding poorly)
|
|
|
Term
Physical Exam for Bacterial Meningitis |
|
Definition
Kernig's Sign
Brudzinski's Neck Sign
Both will hurt if they have meningitis |
|
|
Term
Most Common Bacterial Pathogens of Meningitis |
|
Definition
- Streptococcus pneumoniae (#1)
- Neisseria meningitides
- Haemophilus influenzae type B
- Listeria monocytogenes
- Streptococcus agalactiae (Group B Strep.)
- Escherichia coli or other G-
|
|
|
Term
|
Definition
WBCs
< 5 (adults)
< 20 (newborns)
Diff
70% Lymphocytes
30% Monocytes
Protein
< 50
Glucose
2/3 serum |
|
|
Term
Bacterial Meningitis Lab Results |
|
Definition
WBCs
400-100,000
Diff
80-90% Neutrophils (PMNs)
Protein
Mild to marked elevation (80-500)
Glucose
< 1/2 serum |
|
|
Term
Top 3 Infectious Bacteria that cause Meningitis in Neonates |
|
Definition
- Group B Strep
- E. coli
- Listeria
|
|
|
Term
Characteristics of Pneumococcal Meningitis |
|
Definition
Streptococcus pneumoniae
Most Common Meningitis
Known to Affect:
- Children younger than 2 yrs old
- Adults with weakened immune systems
Causes neurologic damage (deafness to severe brain damage)
|
|
|
Term
Characteristics of Meningococcal Meningitis |
|
Definition
- Highly contagious through droplets
- Primarily children and young adults, those in close quarters, and travelers to foreign countries (West, Central, and East Africa, Pilgrimage to Saudi Arabia)
|
|
|
Term
Clinical Signs of Meningococcal Meningitis |
|
Definition
- Petechial rash or purpuric lesions
- Advances rapidly and can be fatal
- Becomes limb threatening with hours
|
|
|
Term
|
Definition
Streptococcus agalactiae
- Most common cause of meningitis in neonates
- Has been found in pregnant women (asymptomatic)
- Less than half of adult cases had no underlying symptoms
|
|
|
Term
|
Definition
- Found in very young children and older adults
- Crosses placental barrier and causes stillbirth
- Immunocompromised at risk (except HIV)
- Enters through GI tract (coleslaw, raw veggies, milk, cheese)
|
|
|
Term
Aerobic G- Bacilli that cause Meningitis |
|
Definition
In Neonates
- E. coli and Klebsiella spp.
Head trauma or Neurosurgery Patients
- Pseudomonas aeruginosa and others
- MDR strains may need intraventricular doses of antibiotics
|
|
|
Term
Empiric Meningitis Therapy: < 1 month
Common Bacteria and Treatment |
|
Definition
S. agalactiae
E. coli
Listeria monocytogenes
Klebsiella
Ampicillin
+
Cefotaxime or Aminoglycoside |
|
|
Term
Empiric Meningitis Therapy: 1-23 months
Common Bacteria and Treatment |
|
Definition
S. pneumoniae
Neisseria meningitidis
S. agalactiae
H. influenzae type B
E. coli
Vancomycin
+
Ceftriaxone or Cefotaxime |
|
|
Term
Empiric Meningitis Therapy: 2-50 yrs
Common Bacteria and Treatment |
|
Definition
N. meningitidis
S. pneumoniae
Vancomycin
+
Ceftriaxone or Cefotaxime |
|
|
Term
Empiric Meningitis Therapy: > 50 yrs
Common Bacteria and Treatment |
|
Definition
S. pnuemoniae
N. meningitidis
Listeria monocytogenes
Aerobic G- bacilli
Vancomycin
+
Ampicillin
+
Ceftriaxone or Cefotaxime |
|
|
Term
Empiric Meningitis Therapy: Basilar Skull Fracture
Common Bacteria and Treatment |
|
Definition
S. pneumoniae
H. influenzae
Group A Streptococcus pyogenes
Vancomycin
+
Ceftriaxone or Cefotaxime |
|
|
Term
Empiric Meningitis Therapy: Penetrating Head Trauma
Common Bacteria and Treatment |
|
Definition
Staph. aureus
Coagulase - Staph.
Aerobic G - (including P. aeruginosa)
Vancomycin + Cefepime, Ceftazidime, or Meropenem
Important to cover for MRSA and P. aeruginosa
|
|
|
Term
Empiric Meningitis Therapy: Post-Neurosurgery
Common Bacteria and Treatment |
|
Definition
Aerobic G- bacilli
Staph. aureus
Coagulase - Staph.
Vancomycin + Ceftazidime, Cefepime, or Meropenem
Important to cover MRSA and P. aeruginosa |
|
|
Term
Empiric Meningitis Therapy: CSF Shunt
Common Bacteria and Treatment |
|
Definition
Coagulase - Staph.
Staph. aureus
Aerobic G- bacilli
Propionibacterium acnes
Vancomycin + Cefepime, Ceftazidime, or Meropenem
Important to cover MRSA and P. aeruginosa |
|
|
Term
Targeted Therapy for Meningitis
Streptococcus pneumoniae |
|
Definition
Vancomycin
+
3rd Gen Cephalosporin |
|
|
Term
Targeted Therapy for Meningitis
Neisseria meningitidis
|
|
Definition
|
|
Term
Targeted Therapy for Meningitis
Listeria monocytogenes
|
|
Definition
Ampicillin
OR
Penicillin G
Consider adding an aminoglycoside to these |
|
|
Term
Targeted Therapy for Meningitis
Streptococcus agalactiae
|
|
Definition
Ampicillin
OR
Penicillin G
Consider adding an aminoglycoside to these |
|
|
Term
Targeted Therapy for Meningitis
Haemophilus influenzae
|
|
Definition
|
|
Term
Targeted Therapy for Meningitis
Escherichia coli
|
|
Definition
|
|
Term
Antibiotic CSF Penetration: Able to achieve Therapeutic Concentrations |
|
Definition
- TMP/SMX
- Rifampin
- Chloramphenicol
- Anti-TB
|
|
|
Term
Antibiotic CSF Penetration: Not able to achieve Therapeutic Concentrations |
|
Definition
- Aminoglycosides
- 1st and 2nd Gen Cephalosporins
- Clindamycin
- Most Anti-Fungals (Ampho B, Ketoconazole, Itraconazole)
|
|
|
Term
Antibiotic CSF Penetration: Good if inflammation present |
|
Definition
- 3rd Gen Cephalosporins
- Vancomycin
- Penicillins
- Carbapenems
- Aztreonam
- Fluoroquinolones
- Anti-Virals (Acyclovir, Ganciclovir)
- Fluconazole
|
|
|
Term
3 Baseline Clinical Features Associated with Adverse Outcomes |
|
Definition
- Hypotension
- Altered Mental Status
- Seizures
|
|
|
Term
Length of Therapy: Neisseria meningitidis |
|
Definition
|
|
Term
Length of Therapy: Haemophilus influenzae
|
|
Definition
|
|
Term
Length of Therapy: Streptococcus pneumoniae
|
|
Definition
|
|
Term
Length of Therapy: Streptococcus agalaciae
|
|
Definition
|
|
Term
Length of Therapy: Aerobic G- Bacilli |
|
Definition
|
|
Term
Length of Therapy: Listeria monocytogenes |
|
Definition
|
|
Term
In Meningitis, what criteria must be met before the patient can be considered for outpatient therapy? |
|
Definition
- Inpatient antibiotics for > 6 days
- Afebrile for 24-48 hrs
- No neurologic dysfunction or seizures
- Clinically stable or improving
- Home health nursing access
- Reliable IV access
- Daily availability of physician if needed
- Patient and family compliance
- Safe environment
|
|
|
Term
Vaccine Prevention: Haemophilus influenzae type B |
|
Definition
|
|
Term
Vaccine Prevention: Streptococcus pneumoniae |
|
Definition
Infants - haven't completed vaccine series
Elderly - vaccine may be decreasing in effect |
|
|
Term
Vaccine Prevention: Neisseria meningitidis |
|
Definition
|
|